Catalyst Wire Dossier Catalyst Wire Dossier

Abenacianine

· Vergent Bioscience, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Abenacianine, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung [Phase 3]

See pricing